Post by Syensqo

In pharmaceutical packaging, performance, safety, and sustainability can no longer be treated as separate priorities. With Diofan® Super B, Syensqo is helping packaging partners protect sensitive medicines through high barrier performance against water vapor and oxygen, while supporting lower-impact solutions for demanding blister packaging applications. Developed by our advanced packaging team, Diofan® Super B brings together non-fluorosurfactant ultra-high barrier solutions, improved process efficiency, and one of the lowest carbon footprints at equivalent blister film performance. For pharmaceutical manufacturers and packaging partners, this means a solution designed to help safeguard medicine integrity while reducing environmental impact across the packaging value chain. Because protecting medicines should not come at the expense of the planet, we continue to work with our partners to advance solutions that balance performance, safety, and sustainability. We’ll also be attending the 15th Annual InnoPack Pharma Confex. Join Antonio Puppo, Global CTD Engineer at Syensqo, for our Industry Insight session, “Diofan® Solutions: Where Barrier Excellence Meets Sustainability,” on 18 June, 15:20–15:40, and visit us at Booth E2 to continue the conversation. #Syensqo #AdvancingHumanity #WeAreExplorers #PharmaPackaging #InnoPack